Other Assets, Current of BIOGEN INC. from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
BIOGEN INC. quarterly Other Assets, Current in USD history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • BIOGEN INC. Other Assets, Current for the quarter ending 30 Sep 2025 was $916,800,000, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

BIOGEN INC. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $916,800,000 +$242,800,000 +36% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $850,600,000 +$235,300,000 +38% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $757,300,000 -$408,000,000 -35% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $752,500,000 -$429,500,000 -36% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $674,000,000 -$300,100,000 -31% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $615,300,000 -$280,600,000 -31% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $1,165,300,000 -$246,700,000 -17% 31 Mar 2024 10-Q 24 Apr 2024 2024 Q1
Q4 2023 $1,182,000,000 -$235,600,000 -17% 31 Dec 2023 10-K 12 Feb 2025 2024 FY
Q3 2023 $974,100,000 -$521,400,000 -35% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $895,900,000 -$749,400,000 -46% 30 Jun 2023 10-Q 25 Jul 2023 2023 Q2
Q1 2023 $1,412,000,000 +$484,600,000 +52% 31 Mar 2023 10-Q 25 Apr 2023 2023 Q1
Q4 2022 $1,417,600,000 +$676,800,000 +91% 31 Dec 2022 10-K 14 Feb 2024 2023 FY
Q3 2022 $1,495,500,000 +$759,200,000 +103% 30 Sep 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 $1,645,300,000 +$877,400,000 +114% 30 Jun 2022 10-Q 20 Jul 2022 2022 Q1
Q1 2022 $927,400,000 +$141,300,000 +18% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $740,800,000 -$140,300,000 -16% 31 Dec 2021 10-K 15 Feb 2023 2022 FY
Q3 2021 $736,300,000 +$52,800,000 +7.7% 30 Sep 2021 10-Q 20 Oct 2021 2021 Q3
Q2 2021 $767,900,000 +$129,100,000 +20% 30 Jun 2021 10-Q 22 Jul 2021 2021 Q2
Q1 2021 $786,100,000 +$102,300,000 +15% 31 Mar 2021 10-Q 22 Apr 2021 2021 Q1
Q4 2020 $881,100,000 +$250,100,000 +40% 31 Dec 2020 10-K 03 Feb 2022 2021 FY
Q3 2020 $683,500,000 -$59,700,000 -8% 30 Sep 2020 10-Q 21 Oct 2020 2020 Q3
Q2 2020 $638,800,000 -$341,600,000 -35% 30 Jun 2020 10-Q 22 Jul 2020 2020 Q2
Q1 2020 $683,800,000 -$281,600,000 -29% 31 Mar 2020 10-Q 23 Apr 2020 2020 Q1
Q4 2019 $631,000,000 -$56,600,000 -8.2% 31 Dec 2019 10-K 03 Feb 2021 2020 FY
Q3 2019 $743,200,000 -$105,100,000 -12% 30 Sep 2019 10-Q 22 Oct 2019 2019 Q3
Q2 2019 $980,400,000 +$137,100,000 +16% 30 Jun 2019 10-Q 24 Jul 2019 2019 Q2
Q1 2019 $965,400,000 +$69,500,000 +7.8% 31 Mar 2019 10-Q 24 Apr 2019 2019 Q1
Q4 2018 $687,600,000 -$274,400,000 -29% 31 Dec 2018 10-K 06 Feb 2020 2019 FY
Q3 2018 $848,300,000 -$118,700,000 -12% 30 Sep 2018 10-Q 23 Oct 2018 2018 Q3
Q2 2018 $843,300,000 -$302,800,000 -26% 30 Jun 2018 10-Q 24 Jul 2018 2018 Q2
Q1 2018 $895,900,000 -$336,000,000 -27% 31 Mar 2018 10-Q 24 Apr 2018 2018 Q1
Q4 2017 $962,000,000 -$131,300,000 -12% 31 Dec 2017 10-K 06 Feb 2019 2018 FY
Q3 2017 $967,000,000 -$26,100,000 -2.6% 30 Sep 2017 10-Q 24 Oct 2017 2017 Q3
Q2 2017 $1,146,100,000 +$118,700,000 +12% 30 Jun 2017 10-Q 25 Jul 2017 2017 Q2
Q1 2017 $1,231,900,000 +$290,800,000 +31% 31 Mar 2017 10-Q 25 Apr 2017 2017 Q1
Q4 2016 $1,093,300,000 +$256,400,000 +31% 31 Dec 2016 10-K 01 Feb 2018 2017 FY
Q3 2016 $993,100,000 +$131,218,000 +15% 30 Sep 2016 10-Q 26 Oct 2016 2016 Q3
Q2 2016 $1,027,400,000 +$277,361,000 +37% 30 Jun 2016 10-Q 21 Jul 2016 2016 Q2
Q1 2016 $941,100,000 +$361,501,000 +62% 31 Mar 2016 10-Q 21 Apr 2016 2016 Q1
Q4 2015 $836,900,000 +$527,100,000 +170% 31 Dec 2015 10-K 02 Feb 2017 2016 FY
Q3 2015 $861,882,000 +$465,411,000 +117% 30 Sep 2015 10-Q 21 Oct 2015 2015 Q3
Q2 2015 $750,039,000 +$403,252,000 +116% 30 Jun 2015 10-Q 24 Jul 2015 2015 Q2
Q1 2015 $579,599,000 +$284,339,000 +96% 31 Mar 2015 10-Q 24 Apr 2015 2015 Q1
Q4 2014 $309,800,000 +$83,666,000 +37% 31 Dec 2014 10-K 03 Feb 2016 2015 FY
Q3 2014 $396,471,000 +$190,836,000 +93% 30 Sep 2014 10-Q 22 Oct 2014 2014 Q3
Q2 2014 $346,787,000 +$173,079,000 +100% 30 Jun 2014 10-Q 23 Jul 2014 2014 Q2
Q1 2014 $295,260,000 +$125,321,000 +74% 31 Mar 2014 10-Q 23 Apr 2014 2014 Q1
Q4 2013 $226,134,000 +$90,123,000 +66% 31 Dec 2013 10-K 04 Feb 2015 2014 FY
Q3 2013 $205,635,000 +$79,461,000 +63% 30 Sep 2013 10-Q 28 Oct 2013 2013 Q3
Q2 2013 $173,708,000 +$24,461,000 +16% 30 Jun 2013 10-Q 25 Jul 2013 2013 Q2
Q1 2013 $169,939,000 +$47,813,000 +39% 31 Mar 2013 10-Q 25 Apr 2013 2013 Q1
Q4 2012 $136,011,000 -$8,589,000 -5.9% 31 Dec 2012 10-K 06 Feb 2014 2013 FY
Q3 2012 $126,174,000 -$68,025,000 -35% 30 Sep 2012 10-Q 25 Oct 2012 2012 Q3
Q2 2012 $149,247,000 -$52,547,000 -26% 30 Jun 2012 10-Q 24 Jul 2012 2012 Q2
Q1 2012 $122,126,000 -$64,165,000 -34% 31 Mar 2012 10-Q 01 May 2012 2012 Q1
Q4 2011 $144,600,000 -$71,222,000 -33% 31 Dec 2011 10-K 05 Feb 2013 2012 FY
Q3 2011 $194,199,000 -$4,712,000 -2.4% 30 Sep 2011 10-Q 28 Oct 2011 2011 Q3
Q2 2011 $201,794,000 -$16,851,000 -7.7% 30 Jun 2011 10-Q 26 Jul 2011 2011 Q2
Q1 2011 $186,291,000 -$24,004,000 -11% 31 Mar 2011 10-Q 21 Apr 2011 2011 Q1
Q4 2010 $215,822,000 31 Dec 2010 10-K 03 Feb 2012 2011 FY
Q3 2010 $198,911,000 30 Sep 2010 10-Q 26 Oct 2010 2010 Q3
Q2 2010 $218,645,000 30 Jun 2010 10-Q 20 Jul 2010 2010 Q2
Q1 2010 $210,295,000 31 Mar 2010 10-Q 20 Apr 2010 2010 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.